Yang B, Li W, Gao Y, Zhang B, Zuo W
Biomedicines. 2024; 12(11).
PMID: 39595142
PMC: 11592289.
DOI: 10.3390/biomedicines12112576.
Schoepfer A, Safroneeva E
Inflamm Intest Dis. 2024; 9(1):199-209.
PMID: 39474328
PMC: 11521425.
DOI: 10.1159/000540275.
Takedomi H, Fukuda K, Inoue S, Tsuruoka N, Sakata Y, Aoki S
Intest Res. 2024; 23(1):107-111.
PMID: 39205502
PMC: 11834364.
DOI: 10.5217/ir.2024.00013.
Alsohaibani F, Peedikayil M, Alzahrani M, Azzam N, Almadi M, Dellon E
Saudi J Gastroenterol. 2024; 30(4):210-227.
PMID: 38752302
PMC: 11379248.
DOI: 10.4103/sjg.sjg_50_24.
Massironi S, Mulinacci G, Gallo C, Elvevi A, Danese S, Invernizzi P
Cells. 2023; 12(20).
PMID: 37887317
PMC: 10605530.
DOI: 10.3390/cells12202473.
Personalized and Precision Medicine in Asthma and Eosinophilic Esophagitis: The Role of T2 Target Therapy.
Bagnasco D, Savarino E, Yacoub M, Braido F, Candeliere M, Giannini E
Pharmaceutics. 2023; 15(9).
PMID: 37765327
PMC: 10536373.
DOI: 10.3390/pharmaceutics15092359.
Recent Advances in the Treatment of Eosinophilic Esophagitis.
Uchida A, Burk C, Rothenberg M, Furuta G, Spergel J
J Allergy Clin Immunol Pract. 2023; 11(9):2654-2663.
PMID: 37391018
PMC: 10530275.
DOI: 10.1016/j.jaip.2023.06.035.
The role of biologics in pediatric food allergy and eosinophilic gastrointestinal disorders.
Sindher S, Barshow S, Tirumalasetty J, Arasi S, Atkins D, Bauer M
J Allergy Clin Immunol. 2023; 151(3):595-606.
PMID: 36872039
PMC: 9993424.
DOI: 10.1016/j.jaci.2023.01.007.
Biologics in eosinophilic gastrointestinal diseases.
Dellon E, Spergel J
Ann Allergy Asthma Immunol. 2022; 130(1):21-27.
PMID: 35738437
PMC: 10191215.
DOI: 10.1016/j.anai.2022.06.015.
British Society of Gastroenterology (BSG) and British Society of Paediatric Gastroenterology, Hepatology and Nutrition (BSPGHAN) joint consensus guidelines on the diagnosis and management of eosinophilic oesophagitis in children and adults.
Dhar A, Haboubi H, Attwood S, Auth M, Dunn J, Sweis R
Gut. 2022; 71(8):1459-1487.
PMID: 35606089
PMC: 9279848.
DOI: 10.1136/gutjnl-2022-327326.
Type 2 Inflammation in Eosinophilic Esophagitis: From Pathophysiology to Therapeutic Targets.
Racca F, Pellegatta G, Cataldo G, Vespa E, Carlani E, Pelaia C
Front Physiol. 2022; 12:815842.
PMID: 35095572
PMC: 8790151.
DOI: 10.3389/fphys.2021.815842.
Pathophysiology of Non-IgE-Mediated Food Allergy.
Zhang S, Sicherer S, Berin M, Agyemang A
Immunotargets Ther. 2022; 10:431-446.
PMID: 35004389
PMC: 8721028.
DOI: 10.2147/ITT.S284821.
Eosinophilic esophagitis. What diet? How to treat it? The point of view of a gastroenterologist working in a department of allergology.
Kuzminski A, Przybyszewski M, Przybyszewska J, Bartuzi Z
Prz Gastroenterol. 2022; 16(4):318-323.
PMID: 34976239
PMC: 8690950.
DOI: 10.5114/pg.2021.105163.
Eosinophilic Esophagitis: Existing and Upcoming Therapies in an Age of Emerging Molecular and Personalized Medicine.
Slack I, Schwartz J, Mukkada V, Hottinger S, Abonia J
Curr Allergy Asthma Rep. 2020; 20(8):30.
PMID: 32506181
PMC: 8034809.
DOI: 10.1007/s11882-020-00928-2.
Critical Points on the Use of Biologicals in Allergic Diseases and Asthma.
Agache I, Cojanu C, Laculiceanu A, Rogozea L
Allergy Asthma Immunol Res. 2019; 12(1):24-41.
PMID: 31743962
PMC: 6875478.
DOI: 10.4168/aair.2020.12.1.24.
Emerging therapies for eosinophilic esophagitis.
Greuter T, Hirano I, Dellon E
J Allergy Clin Immunol. 2019; 145(1):38-45.
PMID: 31705907
PMC: 6981295.
DOI: 10.1016/j.jaci.2019.10.027.
Pharmacotherapies for the Treatment of Eosinophilic Esophagitis: State of the Art Review.
de Rooij W, Dellon E, Parker C, Feagan B, Jairath V, Ma C
Drugs. 2019; 79(13):1419-1434.
PMID: 31352605
DOI: 10.1007/s40265-019-01173-2.
Climbing New Mountains: How Antibodies Blocking α4β7 Integrins Tamed Eosinophilic Inflammation of the Intestinal Tract.
Olbrich C, Simerly L, de Zoeten E, Furuta G, Spencer L
Dig Dis Sci. 2019; 64(8):2068-2071.
PMID: 31273593
PMC: 6946547.
DOI: 10.1007/s10620-019-05706-3.
